Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Penile Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06353906
What this trial is testing

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

Who this might be right for
Urologic NeoplasmsUrogenital NeoplasmsMale Urogenital Diseases+3 more
The Netherlands Cancer Institute 27
Early research (Phase 1)Looking for participantsNCT06544720
What this trial is testing

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

Who this might be right for
Human Papillomavirus Associated CarcinomasCervical CancerHead and Neck Cancers+5 more
The Affiliated Hospital of Qingdao University 18
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT03012581
What this trial is testing

Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types

Who this might be right for
Carcinoma, Renal CellHead and Neck NeoplasmSkin Neoplasms+3 more
UNICANCER 269
Not applicableNot Yet RecruitingNCT07685249
What this trial is testing

Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment

Who this might be right for
Prostate CancerUrinary IncontinenceErectile Dysfunction
Duke University 30
Early research (Phase 1)Ended earlyNCT04892043
What this trial is testing

Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 5
Not applicableLooking for participantsNCT07378670
What this trial is testing

DEfeating PEnile CAncer-2

Who this might be right for
Penile CancerPenile Neoplasms Malignant
University Hospital Tuebingen 80
Not applicableEnded earlyNCT03323645
What this trial is testing

Prosthetics Registry and Outcomes in Urology at Duke

Who this might be right for
Penile Implantation
Duke University 190
Not applicableTemporarily pausedNCT05842031
What this trial is testing

Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer

Who this might be right for
Penile Cancer
M.D. Anderson Cancer Center 20
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Not applicableStudy completedNCT05887921
What this trial is testing

Inguinal Lymphadenectomy for Penile Cancer

Who this might be right for
Penile CancerLymph Node MetastasisSentinel Lymph Node+1 more
A.O.U. Città della Salute e della Scienza 14
Testing effectiveness (Phase 2)Study completedNCT04357873
What this trial is testing

Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations

Who this might be right for
Squamous Cell Lung CancerVulvar CancerPenile Cancer+3 more
UNICANCER 112
Testing effectiveness (Phase 2)Looking for participantsNCT07110038
What this trial is testing

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

Who this might be right for
Penile Squamous Cell Carcinoma (PSCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 25
Testing effectiveness (Phase 2)Study completedNCT03418480
What this trial is testing

HARE-40: HPV Anti-CD40 RNA vaccinE

Who this might be right for
Human Papilloma Virus Related CarcinomaHead and Neck NeoplasmCervical Neoplasm+2 more
University of Southampton 32
Not applicableStudy completedNCT03241758
What this trial is testing

Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy

Who this might be right for
Prostatic NeoplasmsErectile Dysfunction Following Radical Prostatectomy
Corporacion Parc Tauli 110
Testing effectiveness (Phase 2)Looking for participantsNCT07384416
What this trial is testing

QL1706 Plus Lenvatinib in Previously Treated Penile Cancer

Who this might be right for
Penile Cancer
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Study completedNCT01585428
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Who this might be right for
Cervical CancerOropharyngeal CancerVaginal Cancer+2 more
National Cancer Institute (NCI) 29
Not applicableActive Not RecruitingNCT05592639
What this trial is testing

VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer

Who this might be right for
Penile CancerInguinal LymphadenopathyMelanoma
University College, London 50
Testing effectiveness (Phase 2)Study completedNCT03357757
What this trial is testing

Avelumab With Valproic Acid in Virus-associated Cancer

Who this might be right for
Cancer That is Associated With a Chronic Viral Infectionp16 Positive SCCHNSquamous Cell Carcinoma of the Cervix+5 more
AHS Cancer Control Alberta 39
Early research (Phase 1)Study completedNCT02526316
What this trial is testing

Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers

Who this might be right for
HPV-induced Cancers
Oryx GmbH & Co. KG 11
Next Page